Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Brenntag SE Earnings Release 2023

Nov 9, 2023

70_ip_2023-11-09_6bbd36c4-6bcc-45c1-997e-0d092fff2fcc.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Q3 2023 Results

Brenntag SE November 9, 2023

Q3 2023 Results Presentation

1. Highlights Q3 2023

  1. Financial performance Q3 2023

D

    1. Outlook
    1. Appendix

Highlights Q3 2023

SALES OPERATING GROSS
PROFIT
OPERATING EBITA EPS
EUR 4.1 bn EUR 1 bn EUR 303 m EUR 1.18
- 15.4% vs. PY (fx adj.) - 4.3% vs. PY (fx adj.) 15.3% vs. PY (fx adj.) Q3 2022: EUR 1.60
FREE CASH FLOW SHARE BUYBACK FY 2023 GUIDANCE CAPITAL MARKETS DAY
EUR 442 m 1st tranche
executed
Around
lower end
December 5,
2023 in London

Brenntag continued to manage challenging macroeconomic conditions well in Q3 2023

Macroeconomic environment remains challenging

Ongoing inflationary trends and geopolitical uncertainties

Continued sluggish demand in certain end markets

Slower demand pickup and normalized supply chains lead to declines in chemical prices globally

Brenntag results emphasize resilience of the chemical distribution business model

Benefits from high diversification in product portfolio, customer and supplier base

Indications that customers reach the end of their destocking cycle

With our broad geographical footprint and diversified supplier network, we are well positioned to manage through current uncertainties and continue to be a reliable business partner for our customers globally

Brenntag continues its successful M&A strategy execution

YTD achievements Brenntag acquired 7 companies YTD
More than EUR 370 m Geography Segment Sector / End
Market
Background
EV spent YTD 100
شركة العزاز للكيماويات
Al Azzaz Chemicals Company
BSP Nutrition,
Pharma
▪ One of the largest specialty chemicals
distributor on the Arabian Peninsula
Overall, 7 acquisitions in 2023 AIK MOH ﺗﻮ BES BES Offers a wide range of industrial
chemicals with last-mile delivery, mixing
and blending and value-added services
YD 裏 幅化工
SAIFUCHEMICAL
BSP Personal Care ▪ Market leader in specialty distribution with
expertise in PC Chemicals in China
tuture growth M&A remains a key strategic Avebe BSP Nutrition Avebe is an international cooperative
producing potato starch and protein
pillar tor us and an enabler of Chemgrit SA (Pty) Ltd. BSP PC HI&I Specialty chemicals distributor with tocus
on personal care & tood
Well on track to reach our COLONY GUMS™ BSP Nutrition US based manufacturer of stabilized
blends and blending service provider
planned annual M&A corridor
ot EUR 400 to 500 m in 2023
Old World Industries, LLC BES BES Distribution of Caustic Soda in North
America and strengthening distribution
network in the region

Q3 2023 Results Presentation

  1. Highlights Q3 2023

  2. Financial performance Q3 2023

D

    1. Outlook
    1. Appendix

Financials Q3 2023: Operating EBITA bridges1)

[] 7

Financials Q3 2023: Brenntag Specialties

Financials Q3 2023: Brenntag Essentials

Brenntag Essentials continued to demonstrate its resilience in adverse market conditions and against a very strong Q3 2022

Op. Gross Profit of EUR 622.9 million, a decline of 3.5% vs. PY

Op. EBITDA of EUR 261.6 million, a decline of 9.3% vs. PY

Op. EBITA of EUR 198.8 million, a decrease of 13.4% vs. PY

Margins remained on a high level but normalizing as anticipated

EMEA and NA with lower volumes year-over-year; GP/unit normalization less pronounced in NA, underlining robust performance

Latin America continued to be challenging

Macroeconomic environment characterized by inflationary cost development

Op. EBITA Conversion ratio of 31.9%

Financials Q3 2023: Income statement

in EUR m Q3 2023 Q3 2022 V ‍ Δ FX adjusted
Sales 4,088.3 5,100.5 -19.8% -15.4%
Cost of materials -3,087.7 -3,994.4 -22.7% -
Operating Gross Profit 1,000.6 1,106.1 -9.5% -4.3%
Operating expenses -619.7 -646.4 -4.1% 0.8%
Operating EBITDA 380.9 459.7 -17.1% -11.5%
Depreciation -78.2 -76.2 2.6% 7.8%
Operating EBITA 302.7 383.5 -21.1% -15.3%
Net income / expense from sp. items -23.7 10.3 - -
EBITA 279.0 393.8 -
Amortization -15.3 -17.0 -
EBIT 263.7 376.8 -
Financial result -24.8 -40.0 -
EBT 238.9 336.8 - -
Profit after tax 177.6 248.8 - l
EPS 1:18 1.60 l

Financials Q3 2023: Free cash flow

in EUR m Q3 2023 Q3 2022 <
Operating EBITDA 380.9 459.7 -78.8 -17.1%
Payments to acquire intangible assets and property, plant and equipment -60.5 -52.5 -8.0 15.2%
△ Working capital14) 160.2 -22.6 182.8
Principal and interest payments on lease liabilities -39.0 -37.0 -2.0 5.4%
Free cash flow 441.6 347.6 94.0 27.0%
Working capital turnover (annualized)2) 7.2x 7.5x l

D

Financials Q3 2023: Balance sheet and maturity profile

Q3 2023 Results Presentation

  1. Highlights Q3 2023

  2. Financial performance Q3 2023

  3. Outlook

  4. Appendix

Outlook 20223 Well positioned in a continuously challenging environment

Operating
EBITA
Guidance

■ Brenntag specified its FY 2023 operating EBTA guidance range in Q2 2023 (EUR 1.3bn to EUR 1.4bn, equivalent to an operating EBITDA of EUR 1.6-1.7bn) and now expects FY 2023 operating EBITA to be around the lower end of this range

Comments

■ Forecast takes into account the contributions to earnings from acquisitions already closed and assumes stable fx-rates at the time of the specification of the guidance

Macro environment

Additional

information

■ We expect a continuously tough operating environment, characterized by geo-political uncertainty, macroeconomic challenges but also a sequentially recovering demand across various end markets

  • EUR/USD: ~ 1.08 (2022: ~ 1.05)
  • Sensitivity (FY basis): Delta of EUR/USD +/- 1 cent = EUR ~ -/+ 10m op. EBITA
  • Tax rate: 26-28%
  • Capex 2023: EUR ~300m

Christian Kohlpaintner CEO

Kristin Neumann CFO

Q3 2023 Results Presentation

  1. Highlights Q3 2023

    1. Financial performance Q3 2023
    1. Outlook
    1. Appendix

Financials Q3 2023: Segments (1/2)

in EUR m Operating Gross Profit1) Operating EBITDA2) Conversion ratio
Q3 2023 Q3 2022 A FX
adjusted
Q3 2023 Q3 2022 A FX
adjusted
Q3 2023 Q3 2022
Brenntag Specialties 371.0 420.0 -11.7% -5.5% 146.4 193.4 -24.3% -18.0% 39.5% 46.0%
Brenntag Essentials 622.9 679.3 -8.3% -3.5% 261.6 303.1 -13.7% -9.3% 42.0% 44.6%
All other segments 6.7 6.8 -1.5% -1.5% -27.1 -36.8 26.4% 26.4%
Brenntag Group 1,000.6 1,106.1 -9.5% -4.3% 380.9 459.7 -17.1% -11.5% 38.1% 41.6%
in EUR m Operating EBITA Conversion ratio
Q3 2023 Q3 2022 < ^ FX
adjusted
Q3 2023 Q3 2022
Brenntag Specialties 135.0 182.0 -25.8% -19.6% 36.4% 43.3%
Brenntag Essentials 198.8 241.4 -17.6% -13.4% 31.9% 35.5%
All other segments -31.1 -39.9 22.1% 22.1%
Brenntag Group 302.7 383.5 -21.1% -15.3% 30.3% 34.7%

Financials Q3 2023: Segments (2/2)

in EUR m Operating Gross Profit1) Operating EBITA2) Conversion ratio
Q3 2023 Q3 2022 A A FX
adjusted
Q3 2023 Q3 2022 A FX
adjusted
Q3 2023 Q3 2022
Specialties EMEA 171.5 169.4 1.2% 5.9% 65.5 72.2 -9.3% -2.9% 38.2% 42.6%
Specialties Americas 136.8 179.5 -23.8% -17.8% 47.6 78.4 -39.3% -34.2% 34.8% 43.7%
Specialties APAC 62.7 71.1 -11.8% -2.4% 21.6 31.4 -31.2% -23.6% 34.4% 44.2%
Brenntag Specialties 371.0 420.0 -11.7% -5.5% 135.0 182.0 -25.8% -19.6% 36.4% 43.3%
Essentials EMEA 214.6 237.8 -9.8% -9.2% 66.9 89.1 -24.9% -24.5% 31.2% 37.5%
Essentials North America 343.3 365.7 -6.1% 1.3% 122.7 137.7 -10.9% -3.8% 35.7% 37.7%
Essentials Latin America 38.1 46.5 -18.1% -14.2% 5.5 0.9 -44.4% -42.4% 14.4% 21.3%
Essentials APAC 26.8 29.3 -8.5% 2.6% 4.2 5.5 -23.6% -12.2% 15.7% 18.8%
Brenntag Essentials 622.9 679.3 -8.3% -3.5% 198.8 241.4 -17.6% -13.4% 31.9% 35.5%
All other segments 6.7 6.8 -1.5% -1.5% -31.1 -39.9 22.1% 22.1% -
Brenntag Group 1,000.6 1,106.1 -9.5% -4.3% 302.7 383.5 -21.1% -15.3% 30.3% 34.7%

Note: The difference between the total of the reportable segments (EMEA, Americas and APAC) and the result of central activities which are part of Brenntag divisions but not directly attributable to any specific segment 1) External sales less cost of materials

Financials Q3 2023: Cash flow statement

in EUR m Q3 2023 Q3 2022
Profit after tax 177.6 248.8
Effect from IAS 29 on profit/loss after tax 6.8 1.7
Depreciation & amortization 97.2 92.8
Income tax expense 61.3 87.8
Income taxes paid -64.1 -90.3
Net interest expense 25.3 25.6
Interest paid (netted against interest received) -29.1 -20.0
(thereof interest paid for leases) (-4.7)
-
(-2.4)
Dividends received -
Changes in working capital 160.2 -22.6
Changes in other operating assets and liabilities 8.9 84.4
Changes in provisions 5.6 -19.6
Non-cash change in liabilities relating to acquisition of non-controlling interests -9.8 2.8
Other -4.9 29.1
Net cash provided by operating activities 435.0 420.5

Financials Q3 2023: Cash flow statement (continued)

in EUR m Q3 2023 Q3 2022
Proceeds trom the disposal of other financial assets 0.1 0.5
Proceeds from the disposal of intangible assets and property, plant and equipment 3.8 5.1
Payments to acquire consolidated subsidiaries and other business units - 63.4 -29.7
Payments to acquire intangible assets and property, plant and equipment i - 60.5 - -52.5
Net cash used in investing activities - 120.0 -76.6
Payments to acquire treasury shares -266.1 -
Repayments of liabilities relating to acquisition of non-controlling interests -12.0 -2.0
Proceeds from non-controlling interests
Dividends paid to Brenntag shareholders
Dividends paid to non-controlling interests -3.3 -1.8
Proceeds trom borrowings 9.4 656.4
Repayments of lease liabilities -34.3 -34.6
Repayments of borrowings -96.6 -68.1
Net cash provided by / used in financing activities -402.9 549.9
Change in cash & cash equivalents -87.9 893.8

Financials Q3 2023: Working capital

in EUR m 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022 30 Sep 2022
Inventories 1,459.8 1,547.6 1,661.8 1,773.8 2,019.8
+ Trade receivables 2,481.0 2,519.4 2,693.1 2,676.8 3,029.5
./. Trade payables 1,716.7 1,744.7 1,902.0 1,862.0 2,103.0
Working capital (end of period) 1) 2,224.1 2,322.3 2,452.9 2,588.6 2,946.3
Working capital turnover (annualized)2) 7.2x 7.2x 7.2x 7.5x 7.5x

Financials 9M 2023: Segments (1/2)

in EUR m Operating Gross Profit1) Operating EBITDA2) Conversion ratio
9M 2023 9M 2022 A FX
adjusted
9M 2023 9M 2022 A FX
adjusted
9M 2023 9M 2022
Brenntag Specialties 1,134.0 1,307.6 -13.3% -10.3% 466.1 642.9 -27.5% -24.5% 41.1% 49.2%
Brenntag Essentials 1,909.3 1,954.8 -2.3% -0.4% 835.3 895.9 -6.8% -4.9% 43.7% 45.8%
All other segments 23.7 26.4 -10.2% -10.2% -90.4 -82.3 9.8% 9.8%
Brenntag Group 3,067.0 3,288.8 -6.7% -4.4% 1,211.0 1,456.5 -16.9% -14.3% 39.5% 44.3%
in EUR m Operating EBITA Conversion ratio
9M 2023 9M 2022 A FX
adjusted
9M 2028 9M 2022
Brenntag Specialties 432.7 613.0 -29.4% -26.5% 38.2% 46.9%
Brenntag Essentials 648.6 719.7 -9.9% -8.0% 34.0% 36.8%
All other segments -101.3 -92.5 9.5% 9.5%
Brenntag Group 980.0 1,240.2 -21.0% -18.4% 32.0% 37.7%

Financials 9M 2023: Segments (2/2)

in EUR m Operating Gross Profit1) Operating EBITA2) Conversion Ratio
9M 2023 9M 2022 < A FX
adjusted
9M 2023 9M 2022 A FX
adjusted
9M 2023 9M 2022
Specialties EMEA 519.0 567.0 -8.5% -5.2% 204.8 275.3 -25.6% -21.9% 39.5% 48.6%
Specialties Americas 423.2 515.8 -18.0% -16.0% 156.4 225.8 -30.7% -29.0% 37.0% 43.8%
Specialties APAC 191.8 224.8 -14.7% -10.1% 70.9 111.4 -36.4% -33.0% 37.0% 49.6%
Brenntag Specialties 1,134.0 1,307.6 -13.3% -10.3% 432.7 613.0 -29.4% -26.5% 38.2% 46.9%
Essentials EMEA 695.2 718.5 -3.2% -2.4% 245.9 275.2 -10.6% -9.7% 35.4% 38.3%
Essentials North America 1,029.2 1,003.8 2.5% 4.9% 369.9 378.3 -2.2% 0.1% 35.9% 37.7%
Essentials Latin America 110.5 137.8 -19.8% -17.8% 17.2 37.4 -54.0% -52.5% 15.6% 27.1%
Essentials APAC 74.4 94.7 -21.4% -16.3% 17.2 29.7 -42.1% -38.8% 23.1% 31.4%
Brenntag Essentials 1,909.3 1,954.8 -2.3% -0.4% 648.6 719.7 -9.9% -8.0% 34.0% 36.8%
All other segments 23.7 26.4 -10.2% -10.2% -101.3 -92.5 9.5% 9.5%
Brenntag Group 3,067.0 3,288.8 -6.7% -4.4% 980.0 1,240.2 -21.0% -18.4% 32.0% 37.7%

Note: The difference between the total of the reportable segments (EMEA, Americas and APAC) and the result of central activities which are part of Brenntag divisions but not directly attributable to any specific segment 1) External sales less cost of materials

Financials 9M 2023: Operating EBITA bridges1)

E 24

Financials 9M 2023: Income statement

in EUR m 9M 2023 9M 2022 V ‍^ FX adjusted
Sales 12,872.0 14,694.8 -12.4% -10.2%
Cost of materials -9,805.0 -11,406.0 -14.0% -
Operating Gross Profit 3,067.0 3,288.8 -6.7% -4.4%
Operating expenses -1,856.0 -1,832.3 1.3% 3.5%
Operating EBITDA 1,211.0 1,456.5 -16.9% -14.3%
Depreciation -231.0 -216.3 6.8% 9.1%
Operating EBITA 980.0 1,240.2 -21.0% -18.4%
Net income / expense from sp. items -36.3 4.1 - -
EBITA 943.7 1,244.3 - -
Amortization -49.9 -53.2 -
EBIT 893.8 1,191.1 - -
Financial result -99.2 -102.2
EBT 794.6 1,088.9 -
Profit after tax 583.8 796.9 -
EPS 3.80 5.07 l

Financials 9M 2023: Cash flow statement

in EUR m 9M 2023 9M 2022
Profit after tax 583.8 796.9
Effect from IAS 29 on profit/loss after tax 14.5 8.9
Depreciation & amortization 284.6 268.6
Income tax expense 210.8 290.1
Income taxes paid -212.8 -259.4
Net interest expense 77.4 64.8
Interest paid (netted against interest received) -73.4 -43.8
(thereot interest paid for leases) i (-12.5) i (-7.4)
Dividends received -
Changes in working capital 387.7 -647.5
Changes in other operating assets and liabilities -61.2 49.3
Changes in provisions -33.5 -25.5
Non-cash change in liabilities relating to acquisition of non-controlling interests -7.0 8.1
Other -8.3 43.5
Net cash provided by operating activities 1,162.6 554.0

Financials 9M 2023: Cash flow statement (continued)

in EUR m 9M 2023 9M 2022
Proceeds from the disposal of other financial assets 0.2 0.6
Proceeds from the disposal of intangible assets and property, plant and equipment 10.8 18.3
Payments to acquire consolidated subsidiaries and other business units - 98.1 -30.4
Payments to acquire intangible assets and property, plant and equipment 1- 161.3 -148.8
Net cash used in investing activities - 248.4 -160.3
Payments to acquire treasury shares -439.2
Repayments of liabilities relating to acquisition of non-controlling interests -12.0 -94.0
Proceeds from non-controlling interests 1.7
Dividends paid to Brenntag shareholders -304.7 -224.0
Dividends paid to non-controlling interests -3.5 -2.5
Proceeds trom borrowings 309.8 808.0
Repayments of lease liabilities -102.4 ; -98.9
Repayments of borrowings -860.1 -101.8
Net cash provided by / used in financing activities -1,410.4 286.8
Change in cash & cash equivalents 496.2 680.5

Financials 9M 2023: Free cash flow

in EUR m 9M 2023 9M 2022 <
Operating EBITDA 1,211.0 1,456.5 -245.5 -16.9%
Payments to acquire intangible assets and property, plant and equipment -161.3 -148,8 -12.5 8.4%
Δ Working capital1) 387.7 -647.5 1,035.2
Principal and interest payments on lease liabilities -114.9 -106.3 -8.6 8.1%
Free cash flow 1,322.5 553.9 768.6 138.8%

Financial calendar / contact

B

Date Event Contact
December 5, 2023 Capital Markets Day 2023 Brenntag SE
Corporate Investor Relations
March 7, 2024 Annual Report 2023 Phone: +49 (0) 201 6496 2100
+49 (0) 201 6496 2003
Fax:
May 23, 2024 Annual General Meeting 2024 E-mail: [email protected]
www.brenntag.com/investor relations/
Web:
May 14, 2024 Quarterly Statement Q1 2024

The financial calendar is updated regularly. You can find the latest dates on www.brenntag.com/financial_calendar Please note that these dates could be subject to change.

Disclaimer

This presentation may contain forward-looking statements based on current assumptions and forecasts made by Brenntag SE and other information currently available to the company. Various known and unknown risks, uncertainties and other tactors could lead to material differences between the actual future results, financial situation, development or the company and the estimates given here.

Brenntag SE does not intend, and does not assume any liability whatsoever, to update these forwardlooking statements or to conform them to future events or developments. Some information contained in this document is based on estimates or assumptions of Brenntag SE and there can be no assurance that these estimates or assumptions are or will prove to be accurate.